Short-Term Microgravity Influences Cell Adhesion in Human Breast Cancer Cells by Nassef, Mohamed Z. et al.
 International Journal of 
Molecular Sciences
Article
Short-Term Microgravity Influences Cell Adhesion in
Human Breast Cancer Cells
Mohamed Zakaria Nassef 1, Sascha Kopp 1,*, Daniela Melnik 1, Thomas J. Corydon 2,3 ,
Jayashree Sahana 2, Marcus Krüger 1 , Markus Wehland 1, Thomas J. Bauer 1,
Christian Liemersdorf 4 , Ruth Hemmersbach 4, Manfred Infanger 1 and Daniela Grimm 1,2,5,*
1 Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University Magdeburg,
39120 Magdeburg, Germany; mohamed.nassef@med.ovgu.de (M.Z.N.); daniela.melnik@med.ovgu.de (D.M.);
marcus.krueger@med.ovgu.de (M.K.); markus.wehland@med.ovgu.de (M.W.);
thomas.bauer@med.ovgu.de (T.J.B.); manfred.infanger@med.ovgu.de (M.I.)
2 Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark; corydon@biomed.au.dk (T.J.C.);
jaysaha@biomed.au.dk (J.S.)
3 Department of Ophthalmology, Aarhus University Hospital, 8200 Aarhus N, Denmark
4 Institute of Aerospace Medicine, Department of Gravitational Biology, German Aerospace Center,
51147 Cologne, Germany; christian.liemersdorf@dlr.de (C.L.); ruth.hemmersbach@dlr.de (R.H.)
5 Gravitational Biology and Translational Regenerative Medicine, Faculty of Medicine and Mechanical
Engineering, Otto von Guericke University, 39120 Magdeburg, Germany
* Correspondence: sascha.kopp@med.ovgu.de (S.K.); dgg@biomed.au.dk (D.G.);
Tel.: +49-391-6721267 (S.K.); +45-871-67693 (D.G.)
Received: 11 October 2019; Accepted: 12 November 2019; Published: 15 November 2019 
Abstract: With the commercialization of spaceflight and the exploration of space, it is important to
understand the changes occurring in human cells exposed to real microgravity (r-µg) conditions.
We examined the influence of r-µg, simulated microgravity (s-µg, incubator random positioning
machine (iRPM)), hypergravity (hyper-g), and vibration (VIB) on triple-negative breast cancer (TNBC)
cells (MDA-MB-231 cell line) with the aim to study early changes in the gene expression of factors
associated with cell adhesion, apoptosis, nuclear factor “kappa-light-chain-enhancer” of activated
B-cells (NF-κB) and mitogen-activated protein kinase (MAPK) signaling. We had the opportunity to
attend a parabolic flight (PF) mission and to study changes in RNA transcription in the MDA-MB cells
exposed to PF maneuvers (29th Deutsches Zentrum für Luft- und Raumfahrt (DLR) PF campaign).
PF maneuvers induced an early up-regulation of ICAM1, CD44 and ERK1 mRNAs after the first
parabola (P1) and a delayed upregulation of NFKB1, NFKBIA, NFKBIB, and FAK1 after the last
parabola (P31). ICAM-1, VCAM-1 and CD44 protein levels were elevated, whereas the NF-κB subunit
p-65 and annexin-A2 protein levels were reduced after the 31st parabola (P31). The PRKCA, RAF1,
BAX mRNA were not changed and cleaved caspase-3 was not detectable in MDA-MB-231 cells
exposed to PF maneuvers. Hyper-g-exposure of the cells elevated the expression of CD44 and NFKBIA
mRNAs, iRPM-exposure downregulated ANXA2 and BAX, whereas VIB did not affect the TNBC
cells. The early changes in ICAM-1 and VCAM-1 and the rapid decrease in the NF-κB subunit p-65
might be considered as fast-reacting, gravity-regulated and cell-protective mechanisms of TNBC cells
exposed to altered gravity conditions. This data suggest a key role for the detected gravity-signaling
elements in three-dimensional growth and metastasis.
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1. Introduction
The GLOBOCAN statistics from 2018 showed that breast cancer is the most common cancer
in women and the second leading cause of cancer deaths worldwide [1]. Breast cancer comprises
multiple subtypes with characteristic histology, treatability and outcome [2]. Currently, seven molecular
subtypes are known [3–6]: luminal A (estrogen receptor positive (ER+)/progesterone receptor positive
(PR+)/androgen receptor positive (AR+)/human epidermal growth receptor 2 negative (HER2−)/antigen
KI67 negative (KI67−)), luminal B (ER+/PR+/AR+/HER2−/KI67+), HER2 enriched (ER−/PR−/HER2+),
molecular apocrine (ER−/PR−/AR+/HER2+/KI67+), basal-like/triple-negative (ER−/PR−/AR−/HER2−),
normal breast-like (ER+/PR+/HER2−/KI67−) and claudin-low (ER−/PR−/HER2−). Survival of the
patients is associated with prognostic factors like tumor size, hormone-receptor-profile and metastases
at the time of diagnosis. An onset therapy is the surgical resection of the tumor tissue (lumpectomy or
mastectomy). Tumor size and possible metastases to the sentinel lymph node are decisive for the choice
of following therapy. Chemotherapy, radiation and anti-hormone therapy, targeted treatment against
HER2 and anti-angiogenic therapy are often applied after surgery or in the case of advanced disease
stages [7]. Despite the advanced therapy, it is estimated that about 626,679 deaths wordwide will occur
from breast cancer per year [1]. Therefore, it is necessary to implement novel ideas to find drug targets
and to test new treatment options. This study will focus on the well-described basal-like/triple-negative
cancer (TNBC) and will study the TNBC cell line MDA-MB-231 exposed to short-term altered gravity
conditions and vibration (VIB) [8]. Using altered gravity conditions in the field of cancer research is not
typically the first method to search for target proteins [9], but more than 20 years ago it became clear
that cells exposed to microgravity (µg) opened an alternative view on cancer cells as they revealed
numerous changes like an altered gene expression, protein synthesis and secretion. With the help of
simulated microgravity (s-µg) and mass spectrometry, we found novel protein targets involved in
cancer [10–13]. A space journey and a longer stay on the International Space Station (ISS) provide
altered gravity conditions, which are not found on Earth. On Earth, we can simulate µg to some
extent by applying rotating devices like a 2D or 3D clinostat, the National Aeronautics and Space
Administration (NASA)-developed rotating wall vessel or a random positioning machine (RPM) [14].
Exposure of different cancer cells types to real (r-µg) or simulated (s-)µg-conditions influences various
biological processes, which are of importance in cancer research. Other researchers reported about
changes in the morphological phenotype, growth behavior, gene expression, protein content and
release, cytoskeletal reorganization, extracellular matrix composition, cell adhesion and others [14,15].
One important finding was that in r- and s-µg various cell types form three-dimensional (3D) aggregates
also called multicellular spheroids (MCS), resembling the in vivo situation of tumors much closer
than conventional cell cultures [14]. These MCS are of great interest in cancer research to test drugs
and to find new treatment targets [16]. An activation of nuclear factor “kappa-light-chain-enhancer”
of activated B-cells (NF-κB), a proinflammatory transcription factor, was often detected in breast
cancer [17]. The “inhibitor of κB” (IκB) proteins include IκBα, IκBβ, IκBγ, IκBε, and others [18].
Among them, IκBα, IκBβ and IκBε are the most important regulators of NF-κB and are of high interest
in cancer research and µg-based research. Interestingly, the NF-κB-signaling pathway was significantly
altered in FTC-133 cancer cells [19] as well as in MCF-7 breast cancer cells [20] exposed to s-µg when
MCS were formed. Grosse et al. described an increase in NF-κB p65 protein, when cells were exposed
to s-µg on an RPM [19]. This discovery was in concert with findings by Kopp et al., who described an
activation and increase in NF-κB and associated molecules in MCF-7 cells exposed to the RPM [20].
Through drug-initiated NF-κB inhibition, they were able to reduce the formation of MCS. As it is not
clear when NF-κB signaling is triggered during MCS formation, we exposed MDA-MB-231 breast
cancer cells to r-µg during a parabolic flight campaign (PFC).
The principal aim of this study was, first, to investigate the early phases of r-µg achieved by PF
maneuvers on TNBC cells and to test whether there is a link between factors of apoptosis, changes in
NF-κB signaling and cell adhesion. The second aim was to study VIB and hyper-g (1.8 g) effects on the
MDA-MB-231 cells. In a third approach, we exposed the MDA-MD-231 cells to an incubator RPM (iRPM)
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for 2 h to compare the effects of s-µg with those from r-µg. Afterwards, we performed quantitative
polymerase chain reaction (qPCR) focusing on genes involved in NF-κB signaling, cell adhesion and
MAPK signaling as well as apoptosis. Furthermore, the molecular biological results were finally
evaluated by STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analyses to visualize
the mutual regulation and interactions of genes and proteins examined in this study.
2. Results
2.1. Viability Staining
To examine whether the MDA-MB-231 cells were viable after the VIB-, hyper-g-,
and iRPM-exposure, a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
assay for the detection of DNA fragmentation was performed to measure the amount of apoptotic cells
(Figure 1). Comparing ground controls at Earth’s normal gravity (1 g), VIB, 1.8 g hyper-g (comparable
to the hyper-g exposure on the PFC), and iRPM cell samples, the cytoplasm was evenly stained green,
while the nucleus showed no green staining. In contrast, the positive control, which was treated with
DNase prior to the staining procedure, presents an intensive green staining of the nucleus. This finding
shows, that altered gravity conditions or VIB did not induce apoptosis in MDA-MB-231 cells (Figure 1).
2.2. Nuclear Factor ”Kappa-Light-Chain-Enhancer” of Activated B-Cells (NF-κB) Signaling Factors in
Triple-Negative Breast Cancer Cells during Altered Gravity Conditions
To verify the influence of PF maneuvers on factors involved in the NF-κB-signaling pathway,
the gene expression pattern of NF-κB signaling factors was determined in MDA-MB-231 cells (Figure 2).
As a PF comprises different conditions beside microgravity like hyper-g (1.8 g), and VIB, these factors
had been additionally tested to isolate the effects derived from the exposure to µg (Figure 3).
The major factors of the NF-κB-signaling pathway are NF-κB subunits p105/50, p100/52 and p65
(NFKB3, RELA) of which their corresponding genes are NFKB1, NFKB2 and NFKB3.
While the gene expression of NFKB1 (P31, up-regulation) (Figure 2A) and NFKB3, (RELA;
P1, up-regulation, Figure 2C) are significantly changed after the PF conditions, VIB-, 1.8 g- and
iRPM-exposure had no significant impact on these genes. The NFKB2 mRNA was not altered in any
experimental condition (Figure 2B, Figure 3C,D). In contrast, the Western blot analyses of NF-κB p65
protein presented a significant reduction after P1 and P31 (Figure 2D).
The NF-κB-signaling pathway is modulated by its inhibitors NF-κB-inhibitor-alpha, -beta and
-epsilon (NFKBIA, NFKBIB, NFKBIE) and the NF-κB essential modulator (IKBKG, NEMO). In the case
of NFKBIA, NFKBIB and NFKBIE (Figure 2E,G,H) gene expression, a significant upregulation was
only found for NFKBIA and NFKBIB after P31 compared to their corresponding controls. The NFKBIA
mRNA was differentially expressed by hyper-g (Figure 3G). Protein analyses revealed no significant
change in IκBα and NEMO (Figure 2F,J). The NFKBIE and IKBKG gene expressions (Figure 2H,I) were
not altered in any of the experimental conditions (Figure 3K–N).
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all images with the exception of the positive control. In the positive control, samples have been 
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apoptotic cells as shown in the inserted positive controls. None of the applied experimental 
approaches had induced apoptosis in the cells. 
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Figure 3. Influence of VIB (V), hyper-g and iRPM-exposure on the gene expression of NF-κB
signaling factors: (A,B) NFKB1, (C,D) NFKB2, (E,F) RELA, (G,H) NFKBIA, (I,J) NFKBIB, (K,L) IKBKG,
(M,N) NFKBIE. n = 5. The data are given as mean ± standard deviation. * p < 0.05 vs. corresponding
1 g-controls. The dashed vertical line seperates two independent experiments.
2.3. Expression of Factors Belonging to the Biological Process of Apoptosis
Caspase 3 is a major factor in apoptosis [21]. Gene expression of CASP3 was significantly
upregulat d after P1 and P31 (Figure 4A) while being not regulated after exposure to vibration and
the RPM (Figure 5A,B). Me sur ng the cleaved caspase-3 protein by Western blot analysis and could
not detect any active caspase-3, whereas the positiv control colon cancer cells CX+ exerted a stro g
positivity [21] (Figure 4B).
The g ne expre sion of ANXA1 (Figure 4C, Figure 5C,D) was not significantly changed during
any of the experime tal procedures. ANXA2 mRNA express on showed a similar behavior (Figure 4D,
Figure 5E) except a downregulation after 2h of RPM xposure (Figu e 5F). ANXA2 (annexin A2)
protein (Figure 4E) was first significantly increased aft r P1 and then re-adapted after P31, wh ch is in
agreeme t with the data obtained after a two-hour iRPM-exposu e f the MDA-MB-231 cells (Figure 5F).
In addition, the BAX mRNA wa not differentially regulated (Figure 4F, Figure 5I,J), but BCL2 mRNA
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was reduced at both time points (Figure 4G). Finally, the BAX mRNA was not altered by VIB and
hyper-g, but signicantly reduced in MDA-MB-231 cells exposed to the iRPM (Figure 5G,H).
Int. J. Mol. Sci. 2019, 20, x 7 of 27 
 
 
 
Figure 4. Influence of short-term microgravity on the gene expression: (A) CASP3, (C) ANXA1, (D) 
ANXA2, (F) BAX, (G) BCL2; and protein content (B) caspase 3, (E) annexin 2 regulators of apoptosis. 
The data are given as mean ± standard deviation. * p < 0.05 vs. 1 g-control. CX+ colon cancer cells 
served as positive control for programmed cell death. 
 
Figure 5. Influence of a VIB (V), hyper-g and iRPM-exposure on the gene expression of apoptosis 
signaling factors: (A,B) CASP3, (C,D) ANXA1, (E,F) ANXA2, (G,H) BAX, (I,J) BCL2. n = 5. The data 
are given as mean ± standard deviation. * p < 0.05 vs. 1 g-control. 
Figure 4. Influence of short-term microgravity on the gene expression: (A) CASP3, (C) ANXA1,
(D) ANXA2, (F) BAX, (G) BCL2; and protein content (B) caspase 3, (E) annexin 2 regulators of apoptosis.
The data are given as mean ± standard deviation. * p < 0.05 vs. 1 g-control. CX+ colon cancer cells
served as positive control for programmed cell death.
Int. J. Mol. Sci. 2019, 20, x 7 of 27 
 
 
 
Figure 4. Influence of short-term microgravity on the gene expression: (A) CASP3, (C) ANXA1, (D) 
ANXA2, (F) BAX, (G) BCL2; and protein content (B) caspase 3, (E) annexin 2 regulators of apoptosis. 
The data are given as mean ± standard deviatio . * p < 0.05 vs. 1 g-control. CX+ colon cancer cell  
served as posit  control for programmed cell death. 
 
Figure 5. Influence of a VIB (V), hyper-g and iRPM-exposure on the gene expression of apoptosis 
signaling factors: (A,B) CASP3, (C,D) ANXA1, (E,F) ANXA2, (G,H) BAX, (I,J) BCL2. n = 5. The data 
are given as mean ± standard deviation. * p < 0.05 vs. 1 g-control. 
Figure 5. Influence of a VIB (V), hyper-g and iRPM-exposure on the gene expression of apoptosis
signaling factors: (A,B) CASP3, (C,D) ANXA1, (E,F) ANXA2, (G,H) BAX, (I,J) BCL2. n = 5. The data
are given as mean ± standard deviation. * p < 0.05 vs. 1 g-control.
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2.4. Regulation of Cell Adhesion Molecules in Triple-Negative Breast Cancer (TNBC) Cells
The ICAM1 gene expression was significantly upregulated after one parabola. Although our
data seem to hint towards an additional upregulation after 31 parabolas, the high variability of the
measurements interfered with the statistical analysis (Figure 6A). ICAM1 protein was significantly
reduced after the first parabola and increased after 31 parabolas (Figure 6B). We did not observe
changes in the VCAM1 gene expression (Figure 6C), while VCAM-1 protein levels were significantly
elevated after one and 31 parabolas compared to static 1 g-controls (Figure 6D).
SPP1 gene expression was found to be significantly enhanced compared to the levels after one
parabola, but not to 1 g-controls (Figure 6E). Osteopontin protein expression on the other hand was
significantly downregulated compared to static controls after both one and 31 parabolas (Figure 6F).
Finally, the CD44 gene expression showed a constant increase over the course of the experiment,
with significant rises after one parabola vs. 1 g-controls and 31 parabolas vs. 1 g-controls and levels
after one parabola (Figure 6G). CD44 protein levels followed the same tendency with significant
increases compared to static controls for both one and 31 parabola samples (Figure 6H).
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Figure 6. Expression of genes: (A) ICAM1, (C) VCAM1, (E) SPP1, (G) CD44; and proteins: (B) ICAM-1,
(D) VCAM-1, (F) OPN, (H) CD44 involved in cell adhesion. 1 g: ground control; P1: parabola 1; P31:
parabola 31. The data are given as mean ± standard deviation. * p < 0.05 vs. 1 g-control; ** p < 0.01 vs.
1 g-control.
ICAM1, VCAM1, and SPP1 were not significantly regulated after VIB, hyper-g- or iRPM-exposure
(Figure 7A–F). The CD44 gene expression, on the other hand, was significantly enhanced under
conditions of 1.8 g hyper-g, but remained unchanged by VIB- and iRPM-exposure (Figure 7G,H).
2.5. Factors of the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway Known to be Involved in
Cancer Progression and Metastasis
First, we determined the gene expression of PRKCA (protein kinase C alpha, PKC α). The PRKCA
mRNA was not significantly upregulated after the 31st parabola compared with corresponding
1 g-samples (Figure 8A).
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Then we focused on RAF1 (RAF proto-oncogene serine/threonine-protein kinase). RAF1 remained
unchanged by PF maneuvers (Figure 8B). Afterwards, we measured the ERK1 (extracellular
signal-regulated kinase 1) (Figure 8C) and ERK2 (extracellular signal-regulated kinase 2) (Figure 8D)
gene expression. The ERK1 gene expression was significantly up-regulated after the first parabola
compared to 1 g-samples (Figure 8C). The ERK2 mRNA was significantly elevated after the 31st
parabola compared with P1 r-µg-samples (Figure 8D). There is a direct interaction between ERK1,2 and
FAK1 (focal adhesion kinase 1 also known as PTK2 (protein tyrosine kinase 2)). The FAK1 mRNA was
significantly up-regulated after P31 compared to 1 g-samples (Figure 8E).
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In a next step we measured the MAPK8 (mitogen-activated protein kinase 8) mRNA also called
JNK1 (c-Jun N-Terminal Protein Kinase 1) (Figure 8F). JNK1 was down-regulated after P1 and was not
significantly changed after P31, indicating a rapid short-term effect of microgravity.
2.6. Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) Analysis
The various genes analyzed by qPCR were investigated in regard to their possible interaction and
mutual expression dependence. A STRING/EMBL analysis of these items represented in molecule
action mode is shown in Figure 9. It can be seen that the nuclear factors, whose expression was
analyzed, are regulating each other very strongly, while the remaining items form a loose network.
RELA, NFKB1 and NFKB2, which represent three of the five members of the transcription factor
NF-κB family are strictly controlled at various levels [22]. Their activity is regulated by interaction
with each other, with inhibitors such as NFKBIA, NFKBIB, NFKBIE and with kinases such as IKBKB
(NEMO). The regulation occurs at various levels including the gene expression level. For example,
NFKB1 and RELA form protein heterodimers and are also associated in the regulation of their
expression [23]. Moreover, RELA and VCAM1 are upregulated after an injury of an artery, while NFKBIA
is down-regulated [24] and if annexin A1 is upregulated, it forms a complex with IKFKG that activates
NFKB [25]. On the other hand, the nuclear factors control the transcription of other genes. A target of
RELA is ICAM expression, which is also regulated by osteopontin [26,27]. Osteopontin is co-expressed
with CD44 [28], which co-localizes with annexin A2 [29]. Moreover, there are links between NFKB1
and the expression of CASP3 [30,31]. CASP3 and BAX are upregulated during apoptosis, while BCL2
is downregulated [32]. After the PF maneuvers, we measured increases in CASP3 and a reduction
of BCL2 mRNAs, but no changes in their protein products and no signs of apoptosis. In addition,
we detected an upregulation of ERK1 after P1 compared to 1 g, ERK2 after P31 compared to P1 samples,
and FAK1 after P31 compared to 1 g, whereas PRKCA and RAF1 remained unchanged in short-term µg.
Moreover, the JNK1 gene expression was down-regulated after the first parabola and unaltered after
P31 compared to 1 g.
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presented in the molecule action mode. Gene names are indicated.
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3. Discussion
The basal-like or triple-negative form of breast cancer refers to tumors not expressing the ER, PR,
AR and HER2 genes [1]. This breast cancer type is very heterogeneous, which complicates treatment.
The MDA-MB-231 cell line was isolated from a pleural effusion of a patient with invasive ductal
carcinoma and is ER-, PR-, and E-cadherin negative and expresses mutated p53. Microarray profiling
revealed that the MDA-MB-231 cell genome clusters with the basal subtype of breast cancer. In addition,
MDA-MB-231 cell lack HER2 and thus this cell line is a good model of TNBC [8,33,34].
Gravity is permanently influencing the human body and all life on Earth. Gravitational unloading
results in enormous changes in the organism, organs, tissues and cells [35,36].
Microgravity induces a large number of changes in thyroid and breast cancer cells, such as
alterations of the cytoskeleton, extracellular matrix, focal adhesion, growth behavior, differentiation,
proliferation, cell adhesion or an increased apoptosis [15,20,37–40].
We recently exposed MCF-7 breast cancer cells to the RPM and detected 3D MCS formation within
24 h [20]. The pathway analysis of 47 examined genes proposed that NF-κB variants are involved in
the formation of MCS [20]. This finding was in agreement with data obtained earlier from thyroid
cancer studies [19]. Poorly differentiated FTC-133 follicular thyroid cancer cells cultured on an RPM
for 24 h showed higher levels of NF-κB-p65 protein and apoptosis than 1 g-controls [19]. Both studies
indicated an involvement of NF-κB in 3D growth. No information exists about the early phases when
cells are exposed to µg.
We had the opportunity to attend the 29th Deutsches Zentrum für Luft- und Raumfahrt (DLR) PF
mission in Bordeaux Merignac, France, and to study cells in r-µg (Available online: https://www.dlr.
de/rd/desktopdefault.aspx/tabid-2285/3423_read-47055/; https://www.dlr.de/rd/desktopdefault.aspx/
tabid-2285/3423_read-50372/). We investigated MDA-MB-231 cells in r-µg during PF maneuvers.
The cells were fixed with RNAlater after the first and the 31st parabola, keeping in mind that this last
time point represents a mixture of alternated acceleration phases. Postflight we focused on NF-κB
signaling, cell adhesion, and apoptosis. Furthermore, cells exposed to an iRPM, hyper-g cultures (1.8 g)
and VIB samples were examined to evaluate the impact of these factors on the cells.
3.1. Influence of Altered Gravity Conditions and Vibration on Cell Survival
Apoptosis is involved in the pathogenesis of many diseases including among others ischemia,
autoimmune and neurodegenerative diseases, as well as in tumor response to chemotherapy and/or
radiotherapy [41].
It is known from earlier studies that cancer cells will become apoptotic when exposed to r-µg and
s-µg and that apoptosis is involved in cell detachment and formation of spheroids [19]. Therefore,
we investigated CASP3, ANXA1, ANXA2, BAX and BCL2 mRNA expression patterns.
In our short-term experiments, after a 2-h exposure to s-µg, hyper-g or vibration, TUNEL staining
of TNBC cells revealed no signs of apoptosis and 100% viable cells. The gene expression of CASP3 was
elevated after the first and 31st parabola, but no uncleaved caspase-3 was detectable and no detectable
cleavage of caspase-3 occurred. The CASP3 gene expression was not changed in VIB-, hyper-g- and
s-µg-samples. This is in agreement with earlier findings obtained with endothelial cells exposed to PF
maneuvers [42]. Furthermore, the gene expression of CASP3 and ANXA2 was reduced in endothelial
cells exposed to a two-hour period of VIB or hyper-g conditions [43]. In MDA-MB-231 cells ANXA1
mRNAs were not changed during the parabolic flight, hyper-g-, s-µg- and VIB-exposure. However,
ANXA2 protein after PFC as well as ANXA2 mRNA expression after s-µg exposure was significantly
altered. Thus, µg has an impact on cell survival that is highly dependent on the cell type as well as on
the duration of exposure.
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3.2. Impact of Real Microgravity on NF-κB Signalling in TNBC
NF-κB is an interesting factor because it is associated with spaceflight-related health problems.
Activation of NF-κB is frequently observed in breast cancer as well. An NFKB3 overexpression indicates
increased aggressiveness of breast cancer and a poor prognosis [44]. In addition, NF-κB is involved in
endocrine therapy resistance [45]. Activation of NF-κB promotes the survival of tumor cells. Several
gene products that negatively regulate apoptosis in tumor cells are controlled by NF-κB activation.
The NF-κB proteins include the different variants NF-κB-p50, -p52 and -p65, which are encoded by
the gene loci NFKB1, 2 and 3 [45]. These proteins are bound and inhibited by IκB proteins. The effectors
and inhibitors are activated by external triggers and, thus, interesting in µg-based research.
Human adherent cells exposed to s-µg on a RPM showed elevated levels of NF-κB p65 protein
compared with 1 g-controls, a result found earlier in endothelial cells and in FTC-133 follicular thyroid
cancer cells [19,46].
NF-κB exerts several transcriptional regulatory functions important for programmed cell death [47]
and is inactivated by binding to IκB (inhibitor of NFκB).
The NFKB1 (Nuclear Factor Kappa B Subunit 1) mRNA was significantly elevated after the 31st
parabola compared to 1 g, no changes were measured for the NFKB2 (Nuclear Factor Kappa B Subunit 2)
mRNA at each time point and an upregulated gene was found for NFKB3 (RELA Proto-Oncogene
(V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A), Nuclear Factor NF-Kappa-B P65
Subunit) after the first parabola. NFKB3 mRNA was unaltered after the last parabola (P31). Despite this
result, the corresponding protein NF-κB p65 was down-regulated after the first and 31st parabola.
This counterregulatory effect was not due to VIB or hyper-g occurring during the PF (Figure 3E,F),
as the NFKB3 gene expression was unchanged in VIB and 1.8 g samples. The normalization of NFKB3
after 31 parabolas and the down-regulation of NF-κB p65 protein in short-term r-µg (after one parabola,
that means 22 s of r-µg) is in agreement with earlier microarray data obtained from activated T cells
cultured in space, which showed a suppressed expression of c-REL and NF-κB gene targets after
1.5 h [48]. In addition, a four-hour exposure on the RPM of activated T cells revealed a suppressed
expression of NF-κB gene targets [49].
In many cell types, NF-κB dimers are located in the cytoplasm in an inactive form through
association with any of several IκB inhibitor proteins (IκBα, -β, -ε, -γ, p105 and p100) [50].
The NF-κB signaling pathway is mainly regulated by inhibitor κB (IκB) proteins and the IκB
kinase complex through two major pathways: the canonical and non-canonical NF-κB pathways [50].
We measured significantly elevated NFKBIA and NFKBIB mRNAs after the 31st parabola, whereas
the NFKBIE and IKBKG gene expression were not altered by r-µg (Figure 2). VIB did not affect the
family of cellular IκB proteins inhibiting the NF-κB transcription factors, but hyper-g elevated the
NFKBIA mRNA expression indicating that the measured elevation may be due to the hyper-g phase
of the parabola, because an iRPM-exposure of the MDA-MB-231 cells demonstrated no changes in
NF-κB signaling. On the iRPM all investigated genes remained stably expressed. The RPM aims to
simulate near weightlessness, but one should take note of increased fluid movements—and thus
shear forces—occurring in the flasks,when the device is used for cell cultures experiments [51]. First,
it is important to place the sample as close as possible to the center of rotation in order to minimize
residual g-artifacts and second, the cell culture flasks have to be completely filled with medium
without air bubbles to minimize shear stress. The RPM is used to prepare spaceflight missions and for
tissue engineering purposes. It has proven to be a useful device for long-term cultures of cancer cells
and benign cells [14]. Postflight data revealed that genes and proteins involved in the regulation of
thyroid cancer cell proliferation and metastasis were similarly regulated under RPM and spaceflight
conditions [52].
3.3. Parabolic Flight Maneuvers Changed Cell Adhesion Factors
It is known that s-µg conditions induced changes in the cytoskeleton, ECM, and focal adhesion
factors in various cell types [53,54]. Long-term RPM-exposure of human endothelial cells induced the
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formation of 3D tubular structures and spheroids [55]. In parallel, secretion of the factors ICAM-1,
and VCAM-1 were both increased, when the influence of gravity is minimized for 35 days [55].
In MDA-MB-231 cells exposed to short-term µg on a parabolic flight, an increased synthesis of ICAM-1
protein was found after the P31. A similar result was measured for VCAM-1 protein as given in
Figure 6.
The adhesion molecules ICAM-1 and VCAM-1 are mediating the cell adhesion of cancer cells,
lymphocytes and other cells to the vascular endothelium [56]. Moreover, ICAM-1 is involved in
angiogenesis and is able to increase the survival of microvessels [57].
Primary human macrophages differentiated from monocytes exposed to 11 days r-µg in space on
the ISS revealed a reduced surface expression of ICAM-1, defucosylation of surface proteins and an
altered metabolite spectrum [58]. Another study examined the ICAM-1 protein synthesis and ICAM1
gene expression in cells of the monocyte/macrophage system exposed to r- and s-µg obtained during
2D clinostat, parabolic flight, sounding rocket, and orbital experiments [59]. Murine BV-2 microglial
cells showed a downregulated ICAM1 expression, when exposed to a 2D clinostat and a rapid and
reversible downregulation in the µg-phase of PF maneuvers [59].
Interestingly, an elevated ICAM1 mRNA was measured in macrophage-like differentiated human
U937 cells during the µg-phase of PFs. In non-differentiated U937 cells, no effect of µg was observed [59].
In addition, we studied the early effects of hyper-g, and VIB comparable to the conditions that occur
during PFs on the gene expression of ICAM1 and VCAM1. Both vibration and hypergravity had no effect
on VCAM1 expression. Hyper-g did not change the ICAM1 mRNA expression, while VIB-exposure
of the MDA-MB-231 cells revealed a non-significant result due to the high variation. Furthermore,
the SPP1 gene expression was not altered by VIB and hyper-g, whereas CD44 was unchanged by VIB,
but significantly elevated by hyper-g. Therefore, it can be assumed that the elevated CD44 gene and
protein expression after P31 (Figure 6G,H) is mainly due to hyper-g (Figure 7G). Comparable results
were obtained when poorly differentiated ML-1 follicular thyroid cancer cells were investigated during
a PFC. The SPP1 mRNA was significantly elevated after P31 [60]. The SPP1 gene expression was not
changed by VIB and hyper-g in ML1 follicular thyroid cancer cells [60]. Corresponding data were
obtained when human chondrocytes were studied during PF maneuvers [61]. No significant changes
in the gene expression levels were observed during VIB and hyper-g experiments [61].
In a next step, we focused on the cell-surface glycoprotein CD44 antigen, which is involved in
cell adhesion, migration and cell-cell interactions. The CD44 is a receptor for hyaluronic acid and
interacts with osteopontin. The mRNA expression of CD44 and the corresponding protein content
were both significantly elevated after P1 and P31 compared to 1 g. Similar results were obtained
earlier, when cells were exposed to a NASA rotary cell culture system (RCCS) grown as 3D spheroids
and were CD44-positive [62]. The CD44-positivity of the cells grown in 3D MCS was determined
by immunocytochemistry and was elevated in bladder cancer, prostate cancer, and glioma cell lines
compared with 1 g-cultures [62].
Rat osteoblasts cultured for 4 or 5 days aboard the Space Shuttle and solubilized during spaceflight
revealed strongly elevated CD44 mRNA levels in the flight cultures [63]. In addition, FTC-133 follicular
thyroid cancer cells exposed to an RPM for 24 h expressed a CD44 mRNA which was significantly
up-regulated in adherent cells but not significantly altered in MCS [19]. In addition, an increase in
SPP1 mRNA was measured in adherent FTC-133 cells cultured on the RPM. CD44 can also interact
with SPP1. The SPP1 mRNA was elevated in MDA-MB-231 cells after P31 compared with P1 and 1
g-samples. The synthesis of the protein was reduced during the PF maneuvers (Figure 6F), whereas
both hyper-g and VIB stress had no effect on SPP1. These results are in concert with data obtained
from thyroid cancer cells exposed to the RPM. Simulated µg reduced the amount of osteopontin in
adherent cells and MCS. Based on the role of osteopontin as a mediator of cell-matrix adhesion and
communication, it is influencing tumorigenesis and invasion [64]. Osteopontin seems to be involved in
motility regulation by interaction with CD44 in colon cancer cells, which suggests a role for osteopontin
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in cancer progression [65]. Osteopontin is a potential cancer biomarker [66] and is involved in biological
processes such as cell proliferation, survival, angiogenesis, progression and metastasis [66].
Another study demonstrated that in MDA-MB-231 cells, the inhibition of NF-kB via the chemical
compound Bay-11-7082 results in a CD44 suppression [67]. The NF-kB inhibition and subsequent
CD44 suppression reduced the cell proliferation and invasiveness of breast cancer cells. In contrast in
µg, the cells reacted with a down-regulation of NF-kB p65 protein and an increase in CD44, a finding
which has to be investigated in long-term µg-studies in the future.
3.4. Interaction Network of Selected Genes Evaluated by STRING Analysis
The interaction between CD44 and osteopontin as a potential basis for cancer progression and
metastasis formation is known for a long time [68]. In this study, the up-regulation of the CD44 mRNA
seems to be induced by the hyper-g phases of the PF maneuvers, whereas SPP1 is mainly elevated by
r-µg. Interestingly, the synthesis of osteopontin is reduced, a finding only observed in r-µg.
Furthermore, osteopontin regulates the ICAM-1 and VEGFA expression mainly in
triple-negative/basal-like breast cancer, supporting its role in tumor progression in TNBC [27].
Osteopontin protein was reduced in P31 samples, whereas the ICAM-1 protein synthesis was elevated
after 31 parabolas which may allow for both proteins to conclude a counterregulatory interaction
mechanism in short-term µg.
Another group demonstrated that purified native OPN induces NF-κB activation and
NF-κB-dependent ICAM-1 expression in breast cancer cells [69]. We measured a reduced amount of
NF-κB after P1 and P31 which may be due to the reduced osteopontin content (Figure 2D, Figure 6F).
Both cell adhesion molecules ICAM-1 and VCAM-1 are increased in patients with advanced
breast cancer and the increase in VCAM-1 is of prognostic significance [70]. In our study the VCAM-1
protein synthesis was elevated after P1 and P31. VCAM1 is one of five genes (CXCL12, MMP2, MMP11,
VCAM1, and MME), which were associated with tumor progression, angiogenesis, and metastasis [71].
There is also an interaction between CD44 and ANXA2. ANXA1 together with ANXA2 are both
associated with the aggressive behavior of TNBC [72]. The prognostic impact of ANXA1 relies on a
high ANXA2 expression and both are preferential for TNBC [72]. The MDA-MB-231 cells exhibited a
high expression of ANXA1 and ANXA2. ANXA1 remained stable under all gravity conditions and VIB.
Both, r- and s-µg induced a reduction of ANXA2 protein after 31 parabolas and ANXA2 expression
after 2h RPM exposure. This response seems to be due to altered gravity.
ANXA1 is known to constitutively activate NF-κB in breast cancer cells by interacting with the
IKK complex [25], an interaction that might not to be relevant in µg.
ANXA2 is upregulated in many cancer types and is involved in cancer cell migration, adhesion,
invasion, and metastasis [73]. Intracellular annexin A2 regulates NF-κB signaling by binding to the
p50 subunit in a calcium-independent manner [73]. The ANXA2-p50 complex translocated into the
nucleus [73]. After the first parabola annexin A2 protein synthesis was elevated and then after the 31st
parabola reduced. The NFKB1 mRNA was upregulated after P31, but was not altered under all other
experimental conditions (Figure 2A, Figure 3A,B).
MAPK3 (ERK1) was upregulated after the first parabola and is interacting with RELA, CASP3 and
BCL2. It is known that NF-κB inhibits ERK activation to enhance cell survival during the development
of tumor adaptive radioresistance in breast cancer cells [74]. In addition, ERK1/2 play a key role in
controlling the BCL2-regulated, cell-intrinsic apoptotic pathway [75]. Other interactions are found
for OPN, FAK and ERK1/2 as well as RELA. Integrin αvβ3 binding with OPN mediates the signaling
pathways of FAK, ERK1/2, and NF-κB to activate cellular migration [66], which is important for the
dissemination of cancer cells to distant tissues.
3.5. MAPK Signaling Factors Involved in Cancer Progression and Metastasis
We investigated further factors known to enhance cancer growth and spreading. The protein
kinase C alpha (PKCα) is implicated in cancer progression and associated with a poor prognosis in
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breast cancer patients [76]. There is evidence that PKCα is a key regulator of migration and invasion in
endocrine resistant ER+ breast cancer and basal A TNBC, but not in other subtypes such as endocrine
sensitive ER+ [76]. In this study, we found a slight increase in PRKCA in TNBP exposed to short-term
µg after 31 parabolas. This result was not significant, and thus it may be speculated that PRKCA
is upregulated later, when the cell detachment starts as well as the 3D aggregation of breast cancer
cells [40]. In addition, PRKCA is also a key candidate gene in melanoma metastasis [77]. An important
step for metastasis is that protein kinase C alpha activates RAF-1 by direct phosphorylation [78].
The biological process of the epithelial-mesenchymal transition (EMT) is known to increase
migration and spreading of cancer cells, progression of the cell cycle, and resistance to apoptosis
and chemotherapy. It supports tumor progression. One important signaling pathway involved in
progression and metastasis is the MAPK pathway [79]. Therefore, we determined the RAF1 mRNA
expression. RAF1 works as a regulatory link between the membrane-associated Ras GTPases and the
MAPK/ERK cascade and functions as a switch determining proliferation, differentiation, apoptosis,
survival and oncogenic transformation of human cells [80]. RAF1 activation initiates a mitogen-activated
protein kinase (MAPK) cascade [80]. The fact that it remained unaltered might explain that we did not
find any apoptosis in TNBC exposed to short-term microgravity (Figure 8B).
Furthermore, we measured the expression of ERK1 and ERK2. The ERK subfamily consists of
typical (ERK 1/2/5), and atypical (ERK 3/4/7/8) members. ERKs are involved in the regulation of EMT
and are thus promoting tumor progression. The ERK1 gene expression was significantly up-regulated
after the first parabola compared to 1 g-samples, and ERK 2 after the 31st parabola compared with P1
r-µg-samples (Figure 8D). ERK1 seems to give an initial signal to start 3D aggregation in µg.
Moreover, we focused on the focal adhesion kinase 1 (FAK1), which is also called PTK2 protein
tyrosine kinase 2 (PTK2) and known to increase cancer cell migration and promote metastatic
dissemination to distant sites [81]. Blocking of FAK revealed that breast cancer cells became less
metastatic due to decreased mobility [81]. The FAK1 mRNA was significantly up-regulated after P31
compared to 1 g-samples. This is an interesting result indicating its importance for 3D aggregation,
breast cancer progression and invasion. Chan et al. [82] had demonstrated that the depletion of FAK
induced the formation of active invadopodia and impaired invasive cell migration.
Finally, we measured the MAPK8/JNK1 mRNA in our experimental µg-dependent approach.
The JNK1 gene was down-regulated after the first parabola in the µg-exposed TNBP cells.
It has been shown that JNK1 promotes cell survival in Her2/neu-positive breast cancer [83].
Human studies have shown the relevance of JNK activation to various human cancers [84]. These kinases
are involved in the prevention of malignant transformation via the induction of apoptosis and in
promoting cell survival in established tumors [85]. In addition, there is a potential to monitor JNK
activity as an early biomarker of response to chemotherapy [85]. Therefore, the decrease in JNK1
mRNA expression seems to promote a following 3D formation of the TNBC cells in real µg-conditions.
Taken together, TNBC cells exposed to short-term µg obtained by PF maneuvers kept all signs of a
more aggressive phenotype as elevations of ICAM1 and VCAM1 proteins occurred soon.
MDA-MB-231 cells exposed to short-term r-µg were relatively stable to this external stressor,
vibration and hyper-g.
In summary, an early up-regulation of NFKB1 (P1), NFKB3 (RELA) (P1), ERK1 (P1), ICAM1 (P1),
NFKBIA (P31), NFKBIB (P31), FAK1 (P31), SPP1 (P31) and CD44 (P1, P31) gene expression as well as a
reduced protein content of NF-κB p65 and osteopontin were found after the PF maneuvers. CD44 and
NFKBIA were upregulated in hyper-g, showing that the hyper-g-phase seems to influence both factors.
For all other genes, our data indicate that the microgravity phase is the driving factor of most of these
changes in gene expression. These results are very important because apoptosis is needed for cell
detachment together with an activation of NF-κB-p65 to form 3D growth (spheroids) of cancer cells
when they were exposed to µg. Changes in osteopontin protein suggest a role in survival, angiogenesis,
invasion, and metastasis of TNBC cells.
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4. Materials and Methods
4.1. Cell Culture
MDA-MB-231 cells were purchased from the American Type Culture Collection (ATCC® HTB26™,
Manassas, Virginia, USA)). They were cultured in RPMI 1640 (Life Technologies, Paisley, UK), 10 % FCS
(Sigma Aldrich, Steinheim, Germany) and 1% penicillin/streptomycin (Life Technologies, New York,
USA). The cells were cultured in vented T75 cm2 flasks (Sarstedt, Nümbrecht, Germany) and were
split every 4–5 days to prevent confluence.
4.2. 29th. Parabolic Flight Campaign
The PFs were organized by the DLR in cooperation with Novespace, Bordeaux-Mérignac Airport,
France. The cells were transferred on board of the Airbus A310 (Figure 10A) into a pre-warmed 37 ◦C
incubator shortly before take-off and they were incubated at 37 ◦C for the whole time during the
flight. The flight rack is shown in Figure 10B. Each parabola had an initial phase of hyper-g (1.8 g) for
22 s during pull-up and a final phase of hypergravity for 22 s during pull-out (Figure 10C). The two
hyper-g-phases framed a 22-s long µg-phase. The flight maneuver was repeated 31 times per flight
day. During the PFs, the MDA-MB-231 cells were fixed with RNAlater (Invitrogen by Thermo Fischer
Scientific, Vilnius, Lithuania) at the end of the first parabola (P1) and the end of the last parabola (P31).
The cells were cultured in T75cm2 cell culture flasks (Sarstedt, Nümbrecht, Germany ) with 10 mL
medium in each flask. Each flask had a fixed three-way connector on the lid which was connected
with 140 cm tubing to a 50 mL syringe filled with RNAlater. The RNAlater was injected manually into
the flasks at the designated times. Additional MDA-MB-231 cells were incubated on ground to serve
as static 1 g-controls. The ground control cells were fixed with RNAlater in parallel to the samples
on board of the flight. After landing, the medium and RNAlater mixture was removed and replaced
with 5 mL of fresh RNAlater. The cells were harvested with a 25 cm scraper (Sarstedt, Nümbrecht,
Germany) and stored suspended in RNAlater at 4 ◦C in 15 mL tubes until RNA isolation [54].
4.3. Vibration Experiments
As a PF implements different stressors, vibration was tested on the cells using the Vibraplex device
(DLR, Cologne, Germany) [61,86]. MDA-MB-231 cells were seeded on µ-Slide VI ibiTreat channel slides
(Ibidi, Gräfelfing, Germany) for immunostaining and in T25 cm2 cell culture flasks for RNA isolation.
The flasks and the slides were attached to the Vibraplex platform. The Vibraplex was transferred into a
37 ◦C incubator. Frequencies between 0.2 to 14 Hz were produced via the Vibraplex for a two-hour
duration. These frequencies resemble the VIB produced during the PF. After the vibration procedure,
the cells were fixed with either 4% PFA for immunostaining or RNAlater for RNA isolation. Ground
control slides and flasks were cultured in parallel for comparison.
4.4. Hyper-g Experiments
MDA-MB-231 cells were counted and seeded into µ-Slide VI ibiTreat channel slides (Ibidi,
Gräfelfing, Germany) comparable to [87] for immunostaining. For RNA isolation T 75 cm2 flasks were
used with a confluence of 90%. The flasks and the slides were fixed on swing-out gondolas inside the
DLR multi-sample incubator centrifuge (MuSIC) located inside a 37 ◦C incubator. The centrifuge was
rotating at a constant speed to produce 1.8 g for 2 h which is comparable to the hypergravity phases
produced during the parabolic flight. The device designed by the DLR, Department of Gravitational
Biology, is shown in Figure 10D. At the end of the run, the cells were fixed with either 4% PFA for
immunostaining or RNAlater for RNA isolation. All slides and cell culture flasks were randomly
assigned to centrifugation or 1 g-ground controls.
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4.5. Incubator Random Positioning Machine (iRPM)
The iRPM (Figure 10E) was designed and constructed by Prof. Jörg Sekler-Fachhochschule
Nordwestschweiz. Details of the device were published in [88].
MDA-MB-231 cells were seeded in µ-Slide VI ibiTreat channel slides (Ibidi, Gräfelfing, Germany)
for immunostaining and T25cm2 flasks for RNA isolation. The slides and the flasks were placed
inside a 37 ◦C pre-warmed iRPM. At the end of the 2 h, the cells were fixed with either 4% PFA for
Int. J. Mol. Sci. 2019, 20, 5730 18 of 27
immunostaining or RNAlater for RNA isolation. The RNA was isolated as mentioned earlier. All the
slides and flasks were put in comparison to 1 g-ground control.
4.6. RNA Isolation and Quantitative Polymerase Chain Reaction (qPCR)
All falcon tubes were centrifuged (2500× g for 10 min at 4 ◦C), followed by discarding
the supernatant. The RNA was isolated afterwards using the RNeasy Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s protocol. The quality of the RNA was evaluated with a
spectrophotometer. Afterwards, RNA was converted to cDNA with the High Capacity cDNA reverse
Transcription Kit according to the manufacturer’s protocol (Applied Biosystems, Darmstadt, Germany).
1 µg total RNA in 20 µL reaction mix was prepared as stock for qPCR. The primers were designed
using Primer Blast (primer designing tool from NCBI).
A total volume of 13 µL SYBR green reaction mix (Applied Biosystems, Darmstadt, Germany)
was pipetted in each well in a 96 well plate. 1 µL of cDNA was added to each reaction mix with a
concentration of 100 µM forward and reverse primers. The 7500 Fast Real-Time PCR System (Applied
Biosystems, Darmstadt, Germany) was used to determine the transcription level of targeted genes
(see Table 1). The program consisted of an initial 20 s long holding stage of 95 ◦C followed by the
cycling stage. The cycling stage consisted of 40 cycles of 3 s at 95 ◦C and 30 s at 60 ◦C. A melting curve
was implemented at the end of each run to verify the primer specificity. The data was collected and
analyzed by the ∆∆CT method. 18S rRNA and TBP were used as reference genes.
Table 1. List of primer used during the study. Primer sequences are given in 5′ to 3′ direction.
Factor Primer Name Sequence 5’–3’
18S rRNA
18s-F GGAGCCTGCGGCTTAATTT
18s-R CAACTAAGAACGGCCATGCA
Annexin A1; ANXA1
ANXA1-F GCCAAAGACATAACCTCAGACACAT
ANXA1-R GAATCAGCCAAGTCTTCATTCACA
Annexin A2; ANXA2
ANXA2-F GGTACAAGAGTTACAGCCCTTATGACA
ANXA2-R CATGGAGTCATACAGCCGATCA
BCL2 Associated X, Apoptosis
Regulator; BAX
Bax-F GTCAGCTGCCACTCGGAAA
Bax-R AGTAACATGGAGCTGCAGAGGAT
B-cell lymphoma 2; BCL2
Bcl2-F TCAGAGACAGCCAGGAGAAATCA
Bcl2-R CCTGTGGATGACTGAGTACCTGAA
Caspase 3; CASP3
Casp3-F CTCCAACATCGACTGTGAGAAGTT
Casp3-R GCGCCAGCTCCAGCAA
CD44
CD44-F ACCCTCCCCTCATTCACCAT
CD44-R GTTGTACTACTAGGAGTTGCCTGGATT
Extracellular signal-regulated kinases 1;
ERK1
ERK1-F ACCTGCGACCTTAAGATTTGTGA
ERK1-R AGCCACATACTCCGTCAGGAA
Extracellular signal-regulated kinases 2;
ERK2
ERK2-F TTCCAACCTGCTGCTCAACA
ERK2-R TCTGTCAGGAACCCTGTGTGAT
Focal adhesion kinase 1
(Protein-tyrosine kinase 2); pan-FAK1
FAK1-F TGTGGGTAAACCAGATCCTGC
FAK1-R CTGAAGCTTGACACCCTCGT
Intercellular adhesion molecule 1;
ICAM1
ICAM1-F CGGCTGACGTGTGCAGTAAT
ICAM1-R CTTCTGAGACCTCTGGCTTCGT
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Table 1. Cont.
Factor Primer Name Sequence 5’–3’
Mitogen-activated protein kinase 8
(MAPK8) (JNK1-a2); MAPK8/JNK1
JNK1-F TCTCCTTTAGGTGCAGCAGTG
JNK1-R CAGAGGCCAAAGTCGGATCT
NF-kappa-B transcription complex
P105/P50; NFKB1
NFkB1-F CTTAGGAGGGAGAGCCCAC
NFkB1-R TGAAACATTTGTTCAGGCCTTC
NF-kappa-B transcription complex
P100/P52; NFKB2
NFkB2-F GTACAAAGATACGCGGACCC
NFkB2-R CCAGACCTGGGTTGTAGCA
NF-kappa-B transcription complex P65;
NFKB P65
NFkB P65-F CGCTTCTTCACACACTGGATTC
NFkB P65-R ACTGCCGGGATGGCTTCT
NF-kappa-B essential modulator
(NEMO); IKBKG
IkBKG-F AACTGGGACTTTCTCGGAGC
IkBKG-R GGCAAGGGCTGTCAGCAG
NF-kappa-B inhibitor alpha; NFKBIA
NFkBIa-F AATGCTCAGGAGCCCTGTAAT
NFkBIa-R CTGTTGACATCAGCCCCACA
NF-kappa-B inhibitor beta; NFKBIB
NFkBIb-F CCCGGAGGACCTGGGTT
NFkBIb-R GCAGTGCCGTGTCCCC
NF-kappa-B inhibitor epsilon; NFKBIE
NFkBIe-F TGGGCATCTCATCCACTCTG
NFkBIe-R ACAAGGGATTCCTCAGTCAGGT
Protein kinase C alpha type; PRKCA
PRKCA-F TGGGTCACTGCTCTATGGACTTATC
PRKCA-R CGCCCCCTCTTCTCAGTGT
TATA-box binding protein; TBP
TBP-F GTGACCCAGCATCACTGTTTC
TBP-R GCAAACCAGAAACCCTTGCG
Raf-1 Proto-Oncogene, Serine/Threonine
Kinase; Raf1
Raf1-F GGGAGCTTGGAAGACGATCAG
Raf1-R ACACGGATAGTGTTGCTTGTC
Osteopontin (OPN); SPP1
SPP1-F CGAGGTGATAGTGTGGTTTATGGA
SPP1-R CGTCTGTAGCATCAGGGTACTG
Vascular cell adhesion protein 1;
VCAM1
VCAM1-F CATGGAATTCGAACCCAAACA
VCAM1-R GGCTGACCAAGACGGTTGTATC
4.7. Western Blotting
Western blot analysis, gel electrophoresis, trans-blotting, and densitometry were carried out
following routine protocols as described previously [21,54,61]. Following lysis and centrifugation,
aliquots of 30 µg were subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blotting. The samples were collected at the end of the P1 and P31 and were
compared to 1 g control samples. Each condition is represented with 5 samples with a total number
of 15 samples for all the conditions per cell line. The samples were loaded onto Criterion XT 4–12%
precast gels (Bio-Rad, Hercules, CA, USA) and run for 1 h at 150 V. Proteins were then transferred with
a TurboBlot (Bio-Rad) (100 V, 30 min) to a PVDF membrane. Cofilin-1 was used as a loading control.
Membranes were then blocked for 2 h in TBS-T containing 0.3% I Block (Applied Biosystems, Foster City,
CA, USA). For the detection of the selected antigens (see Table 2), the membranes were incubated
overnight at room temperature in TBS-T and 0.3% I Block solutions of the antibodies. Following three
washing steps of 5 min, the membranes were incubated for a further 2 h at room temperature with
the secondary antibody Horseradish peroxidase (HRP)-linked antibody (Cell Signaling Technology
Inc., Danvers, MA, USA) diluted 1:4000 in TBS-T and 0.3% I-Block. The respective protein bands were
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visualized using Bio-Rad Clarity Western ECL (Bio-Rad) and images were captured with Image Quant
LAS 4000 mini (GE Healthcare Life Science, Freiburg, Germany). Images of stained membranes were
captured on Syngene PXi 4EZ image analysis system (Synoptics, Cambridge, UK) and analyzed using
the ImageJ software for densitometric quantification of the respective bands and total protein load.
Table 2. List of the names, sources, companies, molecular weight and dilutions of all the antibodies
that were used for Western blots.
Antibody kDa Dilution Company Source
Annexin 2 38 1:1000 Abcam #ab41802 Rb
NFkBp65 65 1:1000 Thermo Fisher #PA1-186 Rb
IKBKG 38 1:500 Origene #TA812460 MS
IkBα/NFKBIA 36 1:1000 Invitrogen #MA5-15132 MS
Cofilin-1 20 1:2000 Abcam #ab 42824 Rb
CD44 80 1:500 CST#5640 MS
VCAM1 110 1:500 Sc80431 MS
Casp 3 35 1:800 CST#9662 Rb
ICAM1 90 1:500 CST#4915 Rb
Osteopontin 44 1:1000 SAB4200018 MS
4.8. Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) Staining
The MDA-MB-231 cells were cultured in µ-Slide VI 0.4 ibiTreat Ibidi slides (IBIDI GmbH,
Martinsried, Planegg, Germany), exposed to VIB, hyper-g and iRPM and subsequently collected for
the detection of apoptosis. The method was published earlier in Lützenberg et al. [89].
TUNEL staining was performed according to the manufacturer’s recommendation (Thermo Fisher
Scientific, Waltham, Massachusetts, USA; Click-iT TUNEL Alexa Fluor 488 (cat# C10245)).
The stained cell samples (VIB, hyper-g, iRPM and corresponding static 1 g-controls) were examined
utilizing a Leica DM 2000 microscope equipped with an objective with a calibrated magnification of
400× and connected to an external light source, Leica EL 6000 (Leica Microsystems GmbH, Wetzlar,
Germany). To obtain positive controls the cells were treated with DNAase before the TUNEL staining.
4.9. STRING Analysis
Interactions between proteins were determined using the STRING 10 platform [90]. For each
protein, the UniProtKB entry number was inserted in the input form “multiple proteins” and
“Homo sapiens” was selected as organism. The resulting network view was downloaded in the
molecular action view showing lines between interacting proteins and genes [91].
4.10. Statistical Analyses
GraphPad prism 7.01 (GraphPad Software, Inc., California, USA) was used to analyze the data.
The nonparametric Mann-Whitney U test was used as a statistical test of significance. The difference
between groups was considered significant when the p-value was less than 0.05 (* p < 0.05).
5. Conclusions
Short-term r-µg produced by PF maneuvers induced the gene expression of cell adhesion molecules
in triple-negative breast cancer cells. This finding is in agreement with long-term µg (s- and r-µg) data
with other cell types grown on the NASA-developed high-aspect ratio vessel (HARV) or on the Space
Shuttle in space for 4–5 days [62,63,92]. The CD44 upregulation in the r-µg- and hyper-g-cultures may
be involved in the compensative regulation to counteract cellular apoptosis occurring in µg [93,94].
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Cell adhesion molecules and factors of the MAPK pathway are involved in the adaptive response to
perturbation of mechanical stress under short-term real microgravity. Overall, our study suggests that
a fine balance between NF-κB-p65 and osteopontin gene dosage is required to regulate metastasis,
survival and angiogenesis of TNBC cells.
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Abbreviations
2D Two-dimensional
3D Three-dimensional
ANXA1 Annexin A1
ANXA2 Annexin A2
AR Androgen receptor
ATCC American Type Culture Collection
BAX BCL2 Associated X, Apoptosis Regulator
BCL2 B-cell lymphoma 2
CASP3 Caspase3
CD44 Cell surface glycoprotein CD44
Cx+ Connexin positive
CXCL12 C-X-C Motif Chemokine Ligand 12
CYC1 Cytochrome c1
DLR Deutsches Zentrum für Luft- und Raumfahrt
ECM Extracellular matrix
ER Estrogen receptor
ERK1,2 Extracellular Signal-Regulated Kinase 1, 2
FAK1 Focal adhesion kinase 1
FCS Fetal calf serum
FTC-133 Human follicular thyroid carcinoma cell line
GLOBOCAN Global Cancer Observatory
HARV High-aspect ratio vessel
HER2 Human epidermal growth receptor 2
hyper-g Hypergravity
ICAM1 Intercellular adhesion molecule 1
IKBKG NF-kappa-B essential modulator (NEMO)
IKK IκB kinase
iRPM Incubator random positioning machine
ISS International Space Station
IκB Inhibitor of κB
IκBα Inhibitor of κB alpha
IκBβ Inhibitor of κB beta
IκBγ Inhibitor of κB gamma
IκBε Inhibitor of κB epsilon
JNK1 Mitogen-activated protein kinase 8
KI67 Antigen KI67
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µg Microgravity
MAPK Mitogen-Activated Protein Kinase
MCF-7 Michigan Cancer Foundation-7 cell line
MCS Multicellular spheroids
MDA-MB-231 M.D. Anderson-Metastasis Breast cancer cell line
ML1 Human thyroid carcinoma cell line
MME Membrane Metalloendopeptidase
MMP11 Matrix Metallopeptidase 11
MMP2 Matrix Metallopeptidase 2
MuSIC Multi-sample incubator centrifuge
NFKB1 NF-kappa-B transcription complex P105/P50
NFKB2 NF-kappa-B transcription complex P100/P52
NFKB3/NFKB
P65
NF-kappa-B transcription complex P65
NFKBIA NF-κB-inhibitor-alpha
NFKBIB NF-κB-inhibitor-beta
NFKBIE NF-κB-inhibitor-epsilon
NFκB Nuclear factor-kappaB
P Parabola
PF Parabolic flight
PFA Paraformaldehyde
PR Progesterone receptor
PRKCA Protein kinase C alpha
PTK2 Protein tyrosine kinase 2 (known as FAK1)
qPCR Quantitative polymerase chain reaction
RAF1 RAF proto-oncogene serine/threonine-protein kinase
r-µg Real microgravity
RELA V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A
RPM Random positioning machine
s-µg Simulated microgravity
SPP1/OPN Osteopontin
STRING Search Tool for the Retrieval of Interacting Genes/Proteins
TBP TATA-box binding protein
TNBC Triple-negative breast cancer
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling
VCAM1 Vascular cell adhesion protein 1
VIB Vibration
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